PCOS (Polycystic Ovary Syndrome) Clinical Trials
2 recruiting trials for PCOS (Polycystic Ovary Syndrome). Eligibility criteria explained in plain English.
TrialFinderData lists 2 PCOS (Polycystic Ovary Syndrome) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Every phased trial in this set is Phase 2 (1 of the listed studies); the remaining records are observational or have no phase recorded on ClinicalTrials.gov.
Research is led by Shanghai Zhongshan Hospital (1), Massachusetts General Hospital (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is GLP-1/FGF21 dual agonist (HEC88473) (drug, 1 trial), followed by ActiveGirls Physical Activity Program (Full), ActiveGirls Physical Activity Program (Delayed Lower Intensity).
Track PCOS (Polycystic Ovary Syndrome) trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Efficacy of a GLP-1/FGF21 Dual Agonist for Treating PCOS
Polycystic ovary syndrome (PCOS) is the most common reproductive endocrine and metabolic disorder among women of reproductive age. It is characterized by oligo-ovulation or...
ActiveGirls: Physical Activity, Hormone Health, and Diabetes Risk in Early Adolescence
This study explores how a physical activity program can affect hormone health and diabetes risk in girls ages 8-12 who may be at higher risk. The study aims to address: * Does...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for PCOS (Polycystic Ovary Syndrome), with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for PCOS (Polycystic Ovary Syndrome), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for PCOS (Polycystic Ovary Syndrome), representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.